Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease

D Kaur, V Sharma, R Deshmukh - Inflammopharmacology, 2019 - Springer
Alzheimer's disease (AD) is a neurodegenerative disease that is of high importance to the
neuroscience world, yet the complex pathogenicity is not fully understood. Inflammation is …

Astrocyte dysfunction in Alzheimer disease

C Acosta, HD Anderson… - Journal of neuroscience …, 2017 - Wiley Online Library
Astrocytes are glial cells that are distributed throughout the central nervous system in an
arrangement optimal for chemical and physical interaction with neuronal synapses and …

Luteolin alleviates cognitive impairment in Alzheimer's disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation

J Kou, J Shi, Y He, J Hao, H Zhang, D Luo… - Acta Pharmacologica …, 2022 - nature.com
Luteolin is a flavonoid in a variety of fruits, vegetables, and herbs, which has shown anti-
inflammatory, antioxidant, and anti-cancer neuroprotective activities. In this study, we …

Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice

Y Liu, Y Zhang, X Zheng, T Fang, X Yang, X Luo… - Journal of …, 2018 - Springer
Background Neuroinflammation plays an important role in the onset and progression of
neurodegenerative diseases such as Alzheimer's disease. Lipopolysaccharide (LPS …

Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling

KY Ryu, H Lee, H Woo, RJ Kang, KM Han… - Journal of …, 2019 - Springer
Background The FDA-approved small-molecule drug dasatinib is currently used as a
treatment for chronic myeloid leukemia (CML). However, the effects of dasatinib on …

Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells

P Bharadwaj, T Solomon, BR Sahoo, K Ignasiak… - Scientific Reports, 2020 - nature.com
Human pancreatic islet amyloid polypeptide (hIAPP) and beta amyloid (Aβ) can accumulate
in Type 2 diabetes (T2D) and Alzheimer's disease (AD) brains and evidence suggests that …

Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease

MS Uddin, MT Kabir, D Tewari, A Al Mamun… - Journal of the …, 2020 - Elsevier
Amyloid beta (Aβ) is an intricate molecule that interacts with several biomolecules and/or
produces insoluble assemblies and eventually the nonphysiological depositions of its …

[HTML][HTML] Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer's disease

MSJ Kater, CFM Huffels, T Oshima… - Brain, Behavior, and …, 2023 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive
decline, the neuropathological formation of amyloid-beta (Aβ) plaques and neurofibrillary …

Interrogating amyloid aggregation with aggregation-induced emission fluorescence probes

Y Zhou, J Hua, D Ding, Y Tang - Biomaterials, 2022 - Elsevier
To date, approximately 50 proteins have been identified that can misfold and aggregate to
form amyloid fibrils and cause neurodegenerative diseases such as Alzheimer disease …

Curcumin reduces cognitive deficits by inhibiting neuroinflammation through the endoplasmic reticulum stress pathway in apolipoprotein E4 transgenic mice

J Kou, M Wang, J Shi, H Zhang, X Pu, S Song… - ACS …, 2021 - ACS Publications
Apolipoprotein E4 (ApoE4) is the main genetic risk factor for Alzheimer's disease (AD), but
the exact way in which it causes AD remains unclear. Curcumin is considered to have good …